Unknown OBSERVATIONAL NCT04625166

Combi-elastography Assessment of Chronic Liver Disease Multi-center Study

Sponsor: Chinese PLA General Hospital

Conditions Drug-induced Liver Injury Hepatitis B Non Alcoholic Fatty Liver

Updated 7 times since 2020 Last updated: Jan 9, 2021 Started: Dec 1, 2020 Primary completion: Jan 1, 2022 Completion: Jun 30, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Drug-induced Liver Injury and Hepatitis B and is currently ongoing. Chinese PLA General Hospital leads this study, which shows 7 recorded versions since 2020 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Feb 2023 — Jul 2024 [monthly]

Unknown Status

Status: Recruiting → Unknown Status
Dec 2021 — Feb 2023 [monthly]

Recruiting
Feb 2021 — Dec 2021 [monthly]

Recruiting

▶ Show 2 earlier versions

Jan 2021 — Feb 2021 [monthly]

Recruiting
Dec 2020 — Jan 2021 [monthly]

Recruiting

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Chinese PLA General Hospital

Data source: Chinese PLA General Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Beijing, China